The oncogenic and/or tumour suppressive functions of xanthine oxidase remain contested [46], but a role for xanthine oxidase as a downstream effector within a metabolic-inflammatory circuit, initiated by the nuclear transcriptional coactivator function of hexokinase 2, has been observed in glucose-starved glioma cells [47]. This evidence concerns the gene HK2 and central nervous system cancer.